Congratulations to our client CpG Diagnostics, Inc. for appointing Pascal Bamford as Chief Executive Officer and Board Member.
CpG Diagnostics was founded to transform cancer diagnostics through innovative epigenetic technology. They began with a focus on ovarian cancer, the most lethal gynecologic malignancy, where early detection is challenging yet critical for survival. By licensing groundbreaking technology from leading academic institutions, they’ve developed a powerful platform that can detect the subtle methylation changes that signal the presence of cancer, offering new hope for earlier and more accurate diagnosis.
C1 Team: Christos Richards, Tom Murphy, Evan Fishel, Leo Cain, Todd Aghazadeh